Eisai Presents New Data on the Relationship Between Clinical, Biomarker and Safety Outcomes from the Lecanemab Phase 2B Study Nov 04, 2021 09:39 HKT/SGT Read More
Cryoviva Singapore Gets AABB Accreditation for Somatic Cells' Processing, Storage, and Distribution Nov 02, 2021 08:30 HKT/SGT Read More
エーザイとPRISM BioLab共同創製のCBP/β-catenin 阻害剤 E7386 について、臨床における POC(Proof of Concept:創薬概念の検証)を達成 Nov 01, 2021 10:00 JST Read More
The CREB-binding protein (CBP)/beta-catenin inhibitor E7386, co-created by Eisai and PRISM BioLab, achieved the clinical POC (Proof of Concept) Nov 01, 2021 08:41 HKT/SGT Read More
휴머니젠, 유럽핵의학회에서 임상1상 연구 결과 발표에 이어 고형 종양 관련 이파보투주맙 임상 1b상 연구를 준비하고 있다고 발표함 Oct 31, 2021 14:00 HKT/SGT Read More
휴머니젠, 체스트 연례회의(CHEST Annual Meeting)에서 렌질루맙 치료를 통해 최적의 효과를 볼 수 있을 것으로 보이는 환자군을 파악하기 위한 바이오마커로써의 C-반응성 단백질에 관한 최신 발표 Oct 25, 2021 11:00 HKT/SGT Read More
Universities and DENSO Develop Biosensor to Detect SARS-CoV-2 and Accelerate Development for Practical Application Oct 21, 2021 15:41 HKT/SGT Read More
Avance Clinical Client News: XWPharma Initiates First-in-Human Studies of XW10508, in Development for Fast-acting Relief of Treatment-Resistant Depression and Chronic Pain Oct 19, 2021 15:00 HKT/SGT Read More
Avance Clinical临床试验合作申办方XWPharma正式开启其XW10508首次人类临床试验,研究快速缓解难治性抑郁症以及慢性疼痛疗法 Oct 19, 2021 15:00 HKT/SGT Read More
Avance Clinical臨床試驗合作申辦方XWPharma正式開啟其XW10508首次人類臨床試驗,研究快速緩解難治性抑鬱症以及慢性疼痛療法 Oct 19, 2021 15:00 HKT/SGT Read More
エーザイとMSD、「レンビマ(R)」と「キイトルーダ(R)」の併用療法について進行性腎細胞がんおよび進行性子宮内膜がんに関する承認勧告を欧州医薬品委員会より受領 Oct 18, 2021 09:00 JST Read More
Eisai and Merck & Co., Inc. (Kenilworth, N.J.) Receive Positive EU CHMP Opinions for LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) in Two Different Types of Cancer Oct 18, 2021 08:00 HKT/SGT Read More
Berjaya Partners Holista to Offer Healthy Breads and Foods in Starbucks Malaysia, 7-Eleven and Other F&B Outlets Oct 12, 2021 17:00 HKT/SGT Read More